Legislative Affairs

“One of the penalties of not participating in politics is that you will be governed by your inferiors.”

Plato

The mission of APCI’s Legislative Affairs division is to promote and protect the political and economic interests of all APCI members. In order to accomplish that mission, Legislative Affairs:

  • Provides lobbyist and/or legislative assistance in all APCI member states
  • Identifies pharmacy-friendly political candidates and generate funding to support them
  • Contributes to state associations and organizations with similar legislative focus
  • Identifies political leaders to meet and key meetings or conferences to attend
  • Establishes routine and structured legislative meetings in each state
  • Leverages APCI account representatives and staff personnel
  • Utilizes APCI's Board of Directors to attend selected legislative events
  • Encourages APCI member participation and support of NCPA
  • Maintains a Washington, D.C., presence, supporting NCPA and developing direct relationships

For more information about APCI's Legistative Affairs division, contact us or call (800) 532-2724.

26

Sep

2016

NCPA Advocacy Center Update 9.26.16

In this week's roundup, learn about growing support for federal DIR legislation, Congressional hearings exposing PBM tactics, and more!

22

Sep

2016

Watch Rep. Buddy Carter grill Mylan CEO on EpiPen pricing

U.S. Rep. Buddy Carter grills Mylan CEO Heather Bresch during a hearing on Capitol Hill.

19

Sep

2016

NCPA Advocacy Center Update 9.19.16

In this week's update, new legislation is introduced in the U.S. Senate to end DIR fees, Optum will meet with pharmacies and wholesalers regarding a new policy on distributor accreditation, and more!

8

Aug

2016

NCPA Advocacy Center Update 8.8.16

In this week's update, learn about efforts to get Medicare to address DIR fees, how to host your federal representatives at your pharmacy during the Congressional recess, and more!

28

Jul

2016

PBM practices get attention across the country

Efforts to show how pharmacy benefit managers (PBMs) negatively affect prescription drug pricing are gaining traction, as shown in a number of recent articles around the country.

First 58596061 Last